Product Details
Tecentriq 840 mg/14 mL
Atezolizumab840 mg/14 mL
Concentrate for solution for infusion
ROA
Intravenous
Applicant Name
Roche Products Limited
NRN
A6-100033
Status
Active
Composition
Each 14 mL contains: Atezolizumab 840 mg Excipients: Recombinant Human Hyaluronidase (rHuPH20), L-Histidine, Acetic Acid, L-Methionine, Polysorbate 20, Sucrose, Water for injections
ATC Code/ATCvet Code
L01FF05
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 x 1's (in vial)
Product Description
Concentrate for solution for infusion Clear, colorless to slightly yellowish liquid. The solution has a pH of 5.5 - 6.1 and an osmolality of 129 - 229 mOsm/kg
Manufacturer Name
F. Hoffmann-La Roche Ltd
Manufacturer Country
SWITZERLAND
Approval Date
2021-10-28
Expiry Date
2026-10-27